文献速递泌尿生殖与妇科肿瘤放疗

宫颈癌放化疗期间瘤内免疫细胞活化的动力学

Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-07-12

研究采用微创宫颈细胞刷检法,对20例宫颈癌患者在基线及放化疗第1、3、5周采集瘤内样本,并用多重光谱流式细胞术分析免疫细胞亚群及活化状态。结果显示CD3+总T细胞及CD8+、CD4+ T细胞亚群在第1周较基线显著下降,第3、5周出现不同程度扩增,活化的CD8+CD69+ T细胞比例持续升高,而活化的CD11c+CD11b-树突状细胞比例在第1周最高,许多变化在外周血中未观察不到。作者认为放化疗期间肿瘤部位可能存在免疫激活,并建议除外周血外还应连续分析局部肿瘤微环境。

要点

  • 宫颈癌放化疗第1周瘤内CD3+总T细胞及CD8+、CD4+ T细胞亚群较基线显著下降。
  • 活化的CD8+CD69+ T细胞比例在治疗过程中持续升高。
  • 活化的CD11c+CD11b-树突状细胞比例在第1周最高,许多变化在外周血中未观察不到。

核心结论

  • 放化疗期间瘤内免疫细胞存在动态变化,提示放化疗可能在肿瘤部位具有免疫激活作用。
  • 作者认为除外周血外,连续分析局部肿瘤微环境具有重要性。

研究设计与样本

  • 对20例宫颈癌患者在基线及放化疗第1、3、5周采集宫颈刷检样本。
  • 对9例患者在同一时间点采集匹配的外周血单个核细胞。
  • 采用多重光谱流式细胞术鉴定T细胞和髓系细胞亚群及其活化状态。
  • 采用配对分析Wilcoxon秩和检验计算治疗期间免疫细胞亚群的变化。

主要发现

  • 治疗第1周CD3+总T细胞及CD8+、CD4+ T细胞亚群较基线显著下降,第3、5周出现不同程度扩增。
  • 治疗第3周表达Ki67的增殖性CD8+ T细胞水平升高。
  • 表达CD69的活化CD8+ T细胞百分比在治疗过程中持续升高。
  • 活化的CD11c+CD11b-树突状细胞百分比在第1周最高。
  • 许多上述变化在外周血中未观察不到。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy has direct cytotoxic effects on tumor-infiltrating lymphocytes, but it also has immune stimulatory effects that increase immune cell infiltration. The dynamics of these competing effects on immune cells at the site of the tumor are poorly characterized during chemoradiation treatment (CRT) because of the difficulty of obtaining consecutive tumor biopsies. We used a minimally invasive cervical cytobrushing method to analyze the kinetics of intratumoral immune cell changes in patients with cervical cancer during CRT. METHODS AND MATERIALS: Cervical brushings were obtained from 20 patients with cervical cancer at baseline and during fractionated radiation therapy and cisplatin (weeks 1, 3, and 5). Matching peripheral blood mononuclear cells were obtained from 9 patients at the same time points. Cells were analyzed using multispectral flow cytometry to identify T cell and myeloid cell subsets and their activation status. Changes in immune cell subsets throughout treatment were calculated using matched-pair analysis with Wilcoxon rank sum test. RESULTS: We observed a significant decline in CD3+ total T cells, as well as CD8+ and CD4+ T-cell subsets in the first week of treatment from baseline, followed by variable expansion at weeks 3 and 5. This coincided with higher levels of proliferating CD8+ T cells expressing Ki67 at week 3 of treatment. The percentages of activated CD8+ T cells expressing CD69 continuously increased over the course of treatment, whereas the percentage of activated CD11c+CD11b- dendritic cells was highest during the first week. Many of these changes were not observed in the blood. CONCLUSIONS: Our results identified immune dynamic changes during CRT, indicating that CRT may be immune activating at the site of the tumor. This study also suggests the importance of sequential analyses of the local tumor microenvironment in addition to peripheral blood.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Dorta-Estremera S, Colbert LE, Nookala SS, et al. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30017792. doi:10.1016/j.ijrobp.2018.06.404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。